- call +1-201-465-4211
- email sales@mrinsights.biz
Primary ciliary dyskinesia (PCD), also called immotile ciliary syndrome or Kartagener syndrome, is a rare, ciliopathic, autosomal recessive genetic disorder that causes defects in the action of cilia lining the respiratory tract (lower and upper, sinuses, Eustachian tube, middle ear), fallopian tube, and flagella of sperm cells.
Scope of the Report:
This report studies the Primary Ciliary Dyskinesia market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Primary Ciliary Dyskinesia market by product type and applications/end industries.
There no standardized effective treatment strategies for the condition. Severe fatal respiratory failure can develop; long-term treatment with macrolides such as clarithromycin, erythromycin and azithromycin has been empirically applied for the treatment of primary ciliary dyskinesia in Japan, though controversial due to the effects of the medications.
The global Primary Ciliary Dyskinesia market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Primary Ciliary Dyskinesia.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
AstraZeneca
Boehringer Ingelheim
Novartis
Teva
Bayer
Rotech Healthcare
Pfizer
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Genetic Testing
Electron Microscopy
Market Segment by Applications, can be divided into
Hospitals & Clinics
Research Centers
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Primary Ciliary Dyskinesia Market Overview
1.1 Product Overview and Scope of Primary Ciliary Dyskinesia
1.2 Classification of Primary Ciliary Dyskinesia by Types
1.2.1 Global Primary Ciliary Dyskinesia Revenue Comparison by Types (2017-2023)
1.2.2 Global Primary Ciliary Dyskinesia Revenue Market Share by Types in 2017
1.2.3 Genetic Testing
1.2.4 Electron Microscopy
1.3 Global Primary Ciliary Dyskinesia Market by Application
1.3.1 Global Primary Ciliary Dyskinesia Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals & Clinics
1.3.3 Research Centers
1.4 Global Primary Ciliary Dyskinesia Market by Regions
1.4.1 Global Primary Ciliary Dyskinesia Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Primary Ciliary Dyskinesia Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Primary Ciliary Dyskinesia Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Primary Ciliary Dyskinesia Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Primary Ciliary Dyskinesia Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Primary Ciliary Dyskinesia Status and Prospect (2013-2023)
1.5 Global Market Size of Primary Ciliary Dyskinesia (2013-2023)
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Primary Ciliary Dyskinesia Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Primary Ciliary Dyskinesia Revenue, Gross Margin and Market Share (2016-2017)
2.2 Boehringer Ingelheim
2.2.1 Business Overview
2.2.2 Primary Ciliary Dyskinesia Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Boehringer Ingelheim Primary Ciliary Dyskinesia Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Primary Ciliary Dyskinesia Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Primary Ciliary Dyskinesia Revenue, Gross Margin and Market Share (2016-2017)
2.4 Teva
2.4.1 Business Overview
2.4.2 Primary Ciliary Dyskinesia Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Teva Primary Ciliary Dyskinesia Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bayer
2.5.1 Business Overview
2.5.2 Primary Ciliary Dyskinesia Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bayer Primary Ciliary Dyskinesia Revenue, Gross Margin and Market Share (2016-2017)
2.6 Rotech Healthcare
2.6.1 Business Overview
2.6.2 Primary Ciliary Dyskinesia Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Rotech Healthcare Primary Ciliary Dyskinesia Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Primary Ciliary Dyskinesia Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Primary Ciliary Dyskinesia Revenue, Gross Margin and Market Share (2016-2017)
3 Global Primary Ciliary Dyskinesia Market Competition, by Players
3.1 Global Primary Ciliary Dyskinesia Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Primary Ciliary Dyskinesia Players Market Share
3.2.2 Top 10 Primary Ciliary Dyskinesia Players Market Share
3.3 Market Competition Trend
4 Global Primary Ciliary Dyskinesia Market Size by Regions
4.1 Global Primary Ciliary Dyskinesia Revenue and Market Share by Regions
4.2 North America Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
4.3 Europe Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
4.5 South America Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
5 North America Primary Ciliary Dyskinesia Revenue by Countries
5.1 North America Primary Ciliary Dyskinesia Revenue by Countries (2013-2018)
5.2 USA Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
5.3 Canada Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
5.4 Mexico Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
6 Europe Primary Ciliary Dyskinesia Revenue by Countries
6.1 Europe Primary Ciliary Dyskinesia Revenue by Countries (2013-2018)
6.2 Germany Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
6.3 UK Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
6.4 France Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
6.5 Russia Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
6.6 Italy Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Primary Ciliary Dyskinesia Revenue by Countries
7.1 Asia-Pacific Primary Ciliary Dyskinesia Revenue by Countries (2013-2018)
7.2 China Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
7.3 Japan Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
7.4 Korea Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
7.5 India Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
8 South America Primary Ciliary Dyskinesia Revenue by Countries
8.1 South America Primary Ciliary Dyskinesia Revenue by Countries (2013-2018)
8.2 Brazil Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
8.3 Argentina Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
8.4 Colombia Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Primary Ciliary Dyskinesia by Countries
9.1 Middle East and Africa Primary Ciliary Dyskinesia Revenue by Countries (2013-2018)
9.2 Saudi Arabia Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
9.3 UAE Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
9.4 Egypt Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
9.5 Nigeria Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
9.6 South Africa Primary Ciliary Dyskinesia Revenue and Growth Rate (2013-2018)
10 Global Primary Ciliary Dyskinesia Market Segment by Type
10.1 Global Primary Ciliary Dyskinesia Revenue and Market Share by Type (2013-2018)
10.2 Global Primary Ciliary Dyskinesia Market Forecast by Type (2018-2023)
10.3 Genetic Testing Revenue Growth Rate (2013-2023)
10.4 Electron Microscopy Revenue Growth Rate (2013-2023)
11 Global Primary Ciliary Dyskinesia Market Segment by Application
11.1 Global Primary Ciliary Dyskinesia Revenue Market Share by Application (2013-2018)
11.2 Primary Ciliary Dyskinesia Market Forecast by Application (2018-2023)
11.3 Hospitals & Clinics Revenue Growth (2013-2018)
11.4 Research Centers Revenue Growth (2013-2018)
12 Global Primary Ciliary Dyskinesia Market Size Forecast (2018-2023)
12.1 Global Primary Ciliary Dyskinesia Market Size Forecast (2018-2023)
12.2 Global Primary Ciliary Dyskinesia Market Forecast by Regions (2018-2023)
12.3 North America Primary Ciliary Dyskinesia Revenue Market Forecast (2018-2023)
12.4 Europe Primary Ciliary Dyskinesia Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Primary Ciliary Dyskinesia Revenue Market Forecast (2018-2023)
12.6 South America Primary Ciliary Dyskinesia Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Primary Ciliary Dyskinesia Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Primary Ciliary Dyskinesia Picture
Table Product Specifications of Primary Ciliary Dyskinesia
Table Global Primary Ciliary Dyskinesia and Revenue (Million USD) Marke
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
